Press Releases Year: - Any -201920182017201620152014 Items per page 102550 Date Title and Summary Additional Formats Toggle SummaryFeb 27, 2019 Alder BioPharmaceuticals, Inc. Prices Public Offering of Common Stock View HTML Toggle SummaryFeb 26, 2019 Alder BioPharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Concurrent Private Placement View HTML Toggle SummaryFeb 25, 2019 Alder BioPharmaceuticals® Reports Fourth Quarter and Full Year 2018 Financial and Operating Results View HTML Toggle SummaryFeb 22, 2019 Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML Toggle SummaryFeb 22, 2019 Alder BioPharmaceuticals® Submits Biologics License Application to the U.S. Food and Drug Administration for Eptinezumab View HTML Toggle SummaryFeb 21, 2019 Alder BioPharmaceuticals® to Present at the 8th Annual SVB Leerink Global Healthcare Conference View HTML Toggle SummaryFeb 19, 2019 Alder BioPharmaceuticals® to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial and Operating Results View HTML Toggle SummaryFeb 01, 2019 Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML Toggle SummaryJan 25, 2019 Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) View HTML Toggle SummaryJan 17, 2019 Alder BioPharmaceuticals® Appoints Paul Streck, M.D. Chief Medical Officer View HTML Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 … Next page Next Last page Last
